New drug uptake: qualitative comparison of high and low prescribing GPs' attitudes and approach.
BACKGROUND
Prescribing varies considerably between GPs, and a minority of GPs account for a large proportion of new drug prescribing.


OBJECTIVE
Our aim was to explore the differences in approach and attitudes towards new drug prescribing between high and low GP prescribers.


METHODS
Semi-structured interviews were undertaken with 30 GPs who were either high or low prescribers of new drugs. Interview topics included reasons for prescribing new drugs; use of information sources; attitudes and approach to drug innovation; and consideration of the balance of risk and therapeutic benefit.


RESULTS
Differences in GPs' appraisal of new drugs enabled the development of a classification of attitudes and approaches applying to high and low prescribers. Difference in the behaviours of each group is a matter of degree of attitude or influence rather than (usually) its absence. Key dimensions in the classification are attitudes towards new drug prescribing, perception of risk and benefits, strategies adopted for risk management, information-seeking behaviour and use of the pharmaceutical industry as a significant information source.


CONCLUSIONS
Variability in GP prescribing of new drugs relates not only to levels of acquired knowledge, but also to differences in subjective and ideological beliefs.
D001291:Attitude of Health Personnel; D017723:Drug Utilization Review; D005260:Female; D006801:Humans; D007407:Interviews as Topic; D008297:Male; D010821:Physicians, Family; D010818:Practice Patterns, Physicians'